Items without sitelinks
Showing below up to 50 results in range #661 to #710.
- pyridoxal biosynthetic process (Q21891)
- pyridoxal metabolic process (Q21890)
- pyridoxal import across plasma membrane (Q21889)
- pyridoxal transmembrane transport (Q21888)
- pyridoxal transmembrane transporter activity (Q21887)
- pyridoxal transport (Q21886)
- pyridoxal binding (Q21885)
- nicotinamide mononucleotide transmembrane transporter activity (Q21882)
- nicotinamide mononucleotide transport (Q21881)
- nicotinamide mononucleotide transmembrane transport (Q21880)
- oxidoreductase activity, acting on diphenols and related substances as donors (Q21878)
- dihydronicotinamide riboside quinone reductase activity (Q21877)
- nicotinamide riboside transport (Q21876)
- nicotinamide riboside transmembrane transporter activity (Q21875)
- pyridine nucleoside biosynthetic process (Q21874)
- nicotinamide riboside biosynthetic process (Q21873)
- nicotinamide riboside metabolic process (Q21872)
- pyridine nucleoside metabolic process (Q21871)
- pyridine nucleoside catabolic process (Q21870)
- nicotinamide riboside catabolic process (Q21869)
- constitutional dyserythropoietic anemia (Q21865)
- neoplastic syndrome (Q21864)
- hematologic cancer (Q21863)
- soft tissue disorder (Q21862)
- connective and soft tissue neoplasms (Q21861)
- musculoskeletal neoplasm (Q21860)
- musculoskeletal system cancer (Q21859)
- connective tissue neoplasm (Q21858)
- rare neoplastic disease (Q21857)
- rare tumor (Q21856)
- tumor of hematopoietic and lymphoid tissues (Q21855)
- myeloproliferative disorders (Q21854)
- myelodysplastic syndrome (Q21853)
- bone marrow impairment (Q21852)
- bone marrow disease (Q21851)
- bone marrow failure (Q21850)
- aplastic anemia (Q21849)
- sideroblastic anaemia P (Q21848)
- dyserythropoiesis (Q21847)
- ineffective erythropoiesis (Q21846)
- congenital hemolytic anemia (Q21845)
- congenital dyserythropoietic anemia (Q21844)
- genetic hematologic disease (Q21843)
- neonatal anemia (Q21842)
- congenital anemia (Q21841)
- constitutional deficiency anemia (Q21840)
- vitamin B12- and folate-independent constitutional megaloblastic anemia (Q21839)
- inborn errors of purine–pyrimidine metabolism (Q21838)
- pyrimidine metabolic disorder (Q21837)
- orotic aciduria (Q21836)